Information  X 
Enter a valid email address

IDOX PLC (IDOX)

  Print      Mail a friend       Annual reports

Monday 02 December, 2019

IDOX PLC

Directors' Dealings & Holdings in Company

RNS Number : 3797V
IDOX PLC
02 December 2019
 

 

Idox Plc

 

Directors' Dealings & Holdings in Company

Idox plc (LSE:IDOX, "Company" or "Idox") received notification on 02 December 2019 from Kestrel Partners LLP ("Kestrel") that on 29 November 2019 it acquired, on behalf of its discretionary clients, 200,000 ordinary shares of 1p each ("Shares") in the Company at a price of £0.3515 per share. The notification also included the matters set out below.

Mr Scott, a non-executive director of Idox, is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in one of Kestrel's clients ("Kestrel Opportunities") and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Idox.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 33,537,916 Shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest hold 11,559,362 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 45,097,278 Shares in the Company, which represents 10.18% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

33,537,916

7.57%

Indirect

JIM Nominees Limited

2,421,001

0.55%

Indirect

Bank of New York Nominees Ltd

8,921,616

2.01%

Indirect

Bank of New York Nominees Ltd

225,745

0.05%

 

For further information contact:

 

Idox plc                                                                      +44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

 

N+1 Singer (NOMAD and Broker)                            +44 (0) 20 7496 3000

Shaun Dobson / Jen Boorer (Corporate Finance)

Tom Salvesen (Corporate Broking)

 




ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP ('Kestrel')

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Oliver Rupert Andrew Scott (non-executive director of Idox plc and Partner in Kestrel)

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

IDOX Plc

b)

 

LEI

 

 

213800Z3FE6PWVSUGE70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p Ordinary Shares

 

 

 

ISIN: GB0002998192

 

b)

 

Nature of the transaction

 

 

Transfer for a client account managed by Kestrel to client account held at separate broker. No change of beneficial ownership.

c)

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

GBP 0.3515

 

200,000 Shares

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

Bought 200,000 Shares in total at £0.3515 per share

 

 

e)

 

Date of the transaction

 

2019-11-29

f)

 

Place of the transaction

 

London Stock Exchange

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHEALAAELANFFF

a d v e r t i s e m e n t